Nikhil Lalwani - 26 Nov 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
26 Nov 2024
Net transactions value
-$1,941,442
Form type
4
Filing time
27 Nov 2024, 17:38:49 UTC
Previous filing
10 Sep 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $870,000 +30,000 +8% $29.00 403,859 26 Nov 2024 Direct
transaction ANIP Common Stock Sale $1,738,500 -30,000 -7.4% $57.95 373,859 26 Nov 2024 Direct F1
transaction ANIP Common Stock Sale $202,942 -3,481 -0.93% $58.30 370,378 26 Nov 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise $870,000 -30,000 -18% $29.00 138,027 26 Nov 2024 Common Stock 30,000 $29.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price.
F2 The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price.
F3 25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.